GluT1 inhibitors (IOmet/Merck & Co)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameGluT1 inhibitors (IOmet/Merck & Co)

Drug Alias Nameglucose transporter 1 inhibitors (TPP Global Development)GluT1 inhibitors (TPP Global Development)GluT1 inhibitors (IOmet Pharma)IOM-1723IOM2

ClassificationSmall molecules

Mechanisms of ActionGlucose transporter 1 inhibitors

TargetsGlucose transporter 1

Therapy Area/IndicationsImmune System DiseasesNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesIomet Pharma Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesIomet Pharma Ltd

Active IndicationsN/A

Inactive IndicationsImmune System DiseasesNeoplasms

Other Information

ATC CodeN/A